CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1

CUSIP: 189464AB6

Q3 2015 13F Holders as of 30 Sep 2015

Type / Class
Debt / NOTE 2.500% 9/1
Market price (% of par)
166.75%
Total 13F principal
$293,502,000
Principal change
+$271,957,000
Total reported market value
$488,956,500
Number of holders
28
Value change
+$453,035,500
Number of buys
27

Quarterly Holders Quick Answers

What is CUSIP 189464AB6?
CUSIP 189464AB6 identifies 189464AB6 - CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 as of Q3 2015

As of 30 Sep 2015, CLOVIS ONCOLOGY INC - NOTE 2.500% 9/1 was held by 28 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $293,502,000 in principal (par value) of the bond. The largest 10 bondholders included BAKER BROS. ADVISORS LP, Allianz Asset Management AG, WOLVERINE ASSET MANAGEMENT LLC, Linden Advisors LP, CSS LLC/IL, WELLS FARGO & COMPANY/MN, ADVENT CAPITAL MANAGEMENT /DE/, SYMPHONY ASSET MANAGEMENT LLC, CAPSTONE INVESTMENT ADVISORS, LLC, and Castle Creek Arbitrage, LLC. This page lists 28 institutional bondholders reporting positions for the Q3 2015 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.